Inventor · disambiguated record
Daniel Ortiz
Also filed as: ORTIZ DANIEL · ORTIZ DANIEL JACKSON
9 granted patents·23 pending applications·37 citations·filing 2013–2024
85Inventor score
Top patents by PatentIndex Score
32 records- 0192US11623964B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Apr 11, 2023·6 cites·7 claims
- 0292US11220531B2Engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted Jan 11, 2022·6 cites·5 claims
- 0392US11155640B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Oct 26, 2021·6 cites·2 claims
- 0492US11124573B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Sep 21, 2021·6 cites·40 claims
- 0592US10239944B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·13 cites·24 claims
- 0685US2024141401A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0785US2024167069A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0884US2025011432A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0984US2024279703A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1081US2024067757A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1179US2024209040A1ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1275US11827682B2Engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 1374US12297291B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted May 13, 2025·0 cites·3 claims
- 1474US12071482B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted Aug 27, 2024·0 cites·13 claims
- 1573US2021040527A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1673US2021277438A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1772US2021017563A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1870US2020032312A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1965US2018305725A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2060US2016108450A1Sialylated glycoproteinsMOMENTA PHARMACEUTCALS INC·Filed 2014·Application pending·0 cites
- 2153US2023417762A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2249US2021317227A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2348US2022064298A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CTLA-4MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2448US2021284717A1Compositions and methods related to engineered fc-antigen binding domain constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2548US2022267460A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2648US2021147549A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO PD-L1MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2746US2021238310A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2845US2021269546A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CD38MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2944US2025346676A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CCR4MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3043US2020040084A1Compositions and methods related to engineered fc-antigen binding domain constructsMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3142US2015034748A1Zippy ShakerORTIZ DANIEL JACKSON·Filed 2013·Application pending·0 cites
- 3240US12391759B2Methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 19, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Ortiz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →